SAM
CL icon

Scopus Asset Management’s Colgate-Palmolive CL Stock Holding History

Scopus Asset Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-137,500
Closed -$9.66M – 212
2022
Q3 		$9.66M Buy
+137,500
New +$10.8M 0.36% 93

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Scopus Asset Management's CL Position: Q2 2026 in Review

Scopus Asset Management opened a new position in Colgate-Palmolive (CL) in Q2 2026: 866,500 shares worth $79.4M. The stake represents 1.12% of the portfolio and ranks #11 among its holdings. This is a return to the name: Scopus Asset Management previously reported a position in CL as recently as Q3 2023.

Scopus Asset Management first reported a position in CL in Q1 2017 and has held it in 9 quarters since. 2,021 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Scopus Asset Management held 866,500 shares of Colgate-Palmolive worth $79.4M as of Q2 2026.
  • Colgate-Palmolive was a new Scopus Asset Management position in Q2 2026.
  • Colgate-Palmolive made up 1.12% of Scopus Asset Management's portfolio in Q2 2026, its #11 holding.
  • Scopus Asset Management first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 9 quarters since.
  • 2,021 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Scopus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.